Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,900 | 16 | 70.2% |
| Food and Beverage | $5,837 | 315 | 27.5% |
| Travel and Lodging | $420.92 | 6 | 2.0% |
| Education | $66.03 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $15,794 | 35 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,223 | 65 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $990.99 | 59 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $500.97 | 27 | $0 (2023) |
| Allergan, Inc. | $379.25 | 15 | $0 (2020) |
| Lundbeck LLC | $360.62 | 26 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $342.79 | 24 | $0 (2020) |
| Alkermes, Inc. | $341.98 | 20 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $291.85 | 15 | $0 (2024) |
| ITI, Inc. | $175.29 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $332.58 | 17 | Otsuka America Pharmaceutical, Inc. ($62.42) |
| 2023 | $351.63 | 18 | Otsuka America Pharmaceutical, Inc. ($119.72) |
| 2022 | $204.32 | 12 | ITI, Inc. ($155.02) |
| 2021 | $781.67 | 5 | Indivior Inc. ($715.69) |
| 2020 | $2,877 | 33 | Indivior Inc. ($2,417) |
| 2019 | $13,931 | 113 | Indivior Inc. ($12,574) |
| 2018 | $1,845 | 95 | Otsuka America Pharmaceutical, Inc. ($409.95) |
| 2017 | $900.81 | 47 | Sunovion Pharmaceuticals Inc. ($317.91) |
All Payment Transactions
340 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CNS | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: PSYCHIATRY | ||||||
| 07/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: PSYCHIATRY | ||||||
| 07/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: CNS | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: BH | ||||||
| 04/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: PSYCHIATRY | ||||||
| 04/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: PSYCHIATRY | ||||||
| 03/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Neuropsychiatry | ||||||
| 03/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: CNS | ||||||
| 02/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: PSYCHIATRY | ||||||
| 02/13/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: BH | ||||||
| 12/07/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/16/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: PSYCHIATRY | ||||||
| 11/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Neuroscience | ||||||
| 10/19/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Neuropsychiatry | ||||||
| 08/22/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: PSYCHIATRY | ||||||
| 08/10/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 217 | 296 | $55,412 | $27,715 |
| 2022 | 4 | 262 | 376 | $78,323 | $36,772 |
| 2021 | 9 | 356 | 473 | $87,368 | $49,320 |
| 2020 | 8 | 390 | 511 | $97,582 | $53,699 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 114 | 117 | $30,991 | $14,832 | 47.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 92 | $9,571 | $5,569 | 58.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 56 | $8,969 | $5,133 | 57.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 31 | $5,881 | $2,181 | 37.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 147 | 150 | $41,995 | $19,779 | 47.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 52 | 129 | $18,189 | $10,018 | 55.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 23 | 43 | $8,041 | $3,280 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 26 | $4,862 | $2,153 | 44.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 21 | 28 | $5,236 | $1,543 | 29.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 98 | 103 | $28,092 | $16,312 | 58.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 79 | 136 | $19,074 | $11,030 | 57.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 53 | 55 | $10,230 | $5,866 | 57.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 34 | 71 | $9,946 | $5,465 | 55.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 21 | 21 | $5,859 | $2,981 | 50.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 18 | 25 | $3,650 | $1,986 | 54.4% |
| 90791 | Psychiatric diagnostic evaluation | Facility | 2021 | 14 | 14 | $3,710 | $1,758 | 47.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 16 | $2,336 | $1,532 | 65.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $2,431 | $1,196 | 49.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 21 | $2,040 | $1,194 | 58.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 156 | 163 | $44,518 | $26,146 | 58.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 88 | 145 | $20,384 | $11,902 | 58.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 33 | 61 | $8,766 | $5,051 | 57.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 62 | $9,052 | $3,422 | 37.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 19 | 19 | $5,307 | $2,228 | 42.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 20 | 20 | $3,699 | $2,108 | 57.0% |
About Dr. John Baker, MD
Dr. John Baker, MD is a Psychiatry healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548225519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Baker, MD has received a total of $21,224 in payments from pharmaceutical and medical device companies, with $332.58 received in 2024. These payments were reported across 340 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,900).
As a Medicare-enrolled provider, Baker has provided services to 1,225 Medicare beneficiaries, totaling 1,656 services with total Medicare billing of $167,506. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Lansing, MI
- Active Since 04/20/2006
- Last Updated 06/09/2017
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548225519
Products in Payments
- PERSERIS (Drug) $15,794
- LATUDA (Drug) $990.99
- REXULTI (Drug) $896.31
- ABILIFY MAINTENA (Drug) $567.27
- INVEGA SUSTENNA (Drug) $473.94
- VRAYLAR (Drug) $467.89
- Fanapt (Drug) $315.46
- INGREZZA (Drug) $291.85
- CAPLYTA (Drug) $205.56
- ARISTADA (Drug) $187.61
- AUSTEDO (Drug) $158.63
- Aristada 441 mg (Drug) $154.37
- NUEDEXTA (Drug) $146.04
- BELSOMRA (Drug) $138.70
- NUPLAZID (Drug) $67.90
- Auvelity (Drug) $66.15
- ABILIFY ASIMTUFII (Drug) $61.48
- Trintellix (Drug) $51.51
- TRINTELLIX (Drug) $29.83
- VYVANSE (Drug) $28.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lansing
Ronald Melvin, Do, DO
Psychiatry — Payments: $96,121
Roy Meland, D.o, D.O
Psychiatry — Payments: $10,440
Cynthia Spencer, Do, DO
Psychiatry — Payments: $4,732
Dr. Jimmie Harris, Do, DO
Psychiatry — Payments: $2,103
Jennifer Stanley, Md, MD
Psychiatry — Payments: $1,996
Carol Leader, Do, DO
Psychiatry — Payments: $1,098